Browsing: Drug
Miles Wangan OpenAI researcher whose work involves using artificial intelligence to accelerate scientific and biological discovery is leaving the maker of ChatGPT to launch a new…
Canada’s spy agency says it hacked drug traffickers, extremists and a ransomware gang last year
Offering a rare glimpse into the priorities of a top spy agency, Canada’s Communications Security Establishment (CSE) said it conducted a handful of government-sanctioned hacks last…
Drug discovery is one of the most expensive pursuits in modern industry. Finding a single viable molecule can take a decade and cost billions, and most…
From OpenAI offices to Eli Lilly deal – how Chai Discovery became one of the most impressive names in AI drug development
Drug discovery, the art of identifying new molecules for drug development, is a notoriously time-consuming and difficult process. Traditional techniques such as high performance controlthey offer…
For Daniil Boiko and Andrei Tyrin, the idea for Onepot AI it came from the same frustration. “The best ideas for drug discovery were often held…
With Over 400 million chronic patientsIndia is one of the largest drug markets in the world. However, while most electronic pharmacists are hunting for speed, economic…
Mexican Drug Cartel Hacker pulled the FBI employee’s phone to watch and kill informants, the report says
In 2018, a hacker hired by the Mexican Sinaloa drug cartel run by the famous King Joaquín “El Chapo” Guzmán, Guzmán pulled out the US Embassy…
Investor and Impact Advisor Christian tooley He asked a simple question to the audience at SXSW London last week: What if investors found a way to…
How Automotive Exec Crystal Brown founded Circnova, a biotechnology AI Drug Discovery
Little Michigan Biotechnology Start Cyclic It has garnered a $ 3.3 million seed round for its technology used by AI to target the so -called “circular…
Welcome back to another recap of Equity, TechCrunch’s flagship podcast about the business of startups. This episode is packed with deals, hot topics and the latest…